Detalles de la búsqueda
1.
Direct-acting antivirals in women of reproductive age infected with hepatitis C virus.
J Viral Hepat
; 31(6): 309-319, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38483035
2.
Real-world effectiveness and safety of direct-acting antivirals in patients with cirrhosis and history of hepatic decompensation: Epi-Ter2 Study.
Liver Int
; 41(8): 1789-1801, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33655628
3.
Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all hepatitis C virus infected patients in the real-world experience?
J Gastroenterol Hepatol
; 36(7): 1944-1952, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33171526
4.
Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.
J Gastroenterol Hepatol
; 35(7): 1238-1246, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31734959
5.
Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up.
J Viral Hepat
; 26(1): 109-117, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187612
6.
The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study.
BMC Infect Dis
; 18(1): 580, 2018 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-30445916
7.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
J Hepatol
; 64(1): 19-28, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26321288
8.
Adding pegylated interferon to entecavir for hepatitis B e antigen-positive chronic hepatitis B: A multicenter randomized trial (ARES study).
Hepatology
; 61(5): 1512-22, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25348661
9.
Quantification of HBsAg in nucleos(t)ide-naïve patients treated for chronic hepatitis B with entecavir with or without tenofovir in the BE-LOW study.
J Hepatol
; 62(1): 56-63, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25176615
10.
Efficacy of immunotherapy with TG4040, peg-interferon, and ribavirin in a Phase 2 study of patients with chronic HCV infection.
Gastroenterology
; 147(1): 119-131.e3, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24657484
11.
Treatment of the most difficult-to-cure hepatitis C virus-infected population with sofosbuvir / velpatasvir.
Pol Arch Intern Med
; 134(2)2024 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38164647
12.
Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people.
Minerva Med
; 2024 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38591836
13.
Real-life effectiveness of antiviral therapy for HCV infection with pangenotypic regimens in HIV coinfected patients.
Expert Rev Anti Infect Ther
; : 1-6, 2024 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38722307
14.
Laboratory-based scoring system for prediction of hepatic inflammatory activity in patients with autoimmune hepatitis.
Liver Int
; 33(9): 1370-7, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23651331
15.
Intensified peginterferon α-2a dosing increases sustained virologic response rates in heavy, high viral load hepatitis C genotype 1 patients with high low-density lipoprotein.
J Clin Gastroenterol
; 47(3): 271-9, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22951527
16.
Serum ghrelin in female patients with rheumatoid arthritis during treatment with infliximab.
Rheumatol Int
; 33(6): 1611-3, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198659
17.
Real-World Effectiveness and Safety of Direct-Acting Antivirals in Patients with Chronic Hepatitis C and Epilepsy: An Epi-Ter-2 Study in Poland.
J Pers Med
; 13(7)2023 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37511724
18.
Rescue Therapy after Failure of HCV Antiviral Treatment with Interferon-Free Regimens.
Viruses
; 15(3)2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36992388
19.
Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era.
World J Gastroenterol
; 29(13): 2015-2033, 2023 Apr 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37155527
20.
Does a detectable HCV RNA at the end of DAA therapy herald treatment failure?
Antiviral Res
; 220: 105742, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37944825